Literature DB >> 15179939

The role of the angiopoietins in tumour angiogenesis.

M J Plank1, B D Sleeman, P F Jones.   

Abstract

Angiogenesis--the growth of new blood vessels from existing ones--is a prerequisite for the growth of solid tumours beyond a diameter of approximately 2 mm. In recent years, the angiopoietins have emerged as important regulators of angiogenesis. They mediate a delicate balance between vascular quiescence, regression and new growth, but their mechanism of action is not fully understood. This work attempts to provide a mathematical description of the role of the angiopoietins in angiogenesis. The model is formulated within the framework of reinforced random walks, which allows easy transition between the continuum (macroscopic) and discrete (microscopic) forms. Model predictions are in qualitative agreement with experimental observations, and may have implications for antiangiogenic cancer therapies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15179939     DOI: 10.1080/08977190310001643218

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  7 in total

1.  Angiogenesis and multiple myeloma.

Authors:  Nicola Giuliani; Paola Storti; Marina Bolzoni; Benedetta Dalla Palma; Sabrina Bonomini
Journal:  Cancer Microenviron       Date:  2011-07-07

2.  ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia.

Authors:  Silvia Martinelli; Meena Kanduri; Rossana Maffei; Stefania Fiorcari; Jenny Bulgarelli; Roberto Marasca; Richard Rosenquist
Journal:  Epigenetics       Date:  2013-05-14       Impact factor: 4.528

3.  Prognostic impact of angiopoietin-2 in multiple myeloma.

Authors:  Constantina A Pappa; Michael G Alexandrakis; Anna Boula; Aspasia Thanasia; Ioannis Konsolas; Athanasios Alegakis; George Tsirakis
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-08       Impact factor: 4.553

4.  Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategies.

Authors:  Chrysovalantis Voutouri; Nathaniel D Kirkpatrick; Euiheon Chung; Fotios Mpekris; James W Baish; Lance L Munn; Dai Fukumura; Triantafyllos Stylianopoulos; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-30       Impact factor: 11.205

5.  Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses.

Authors:  Chheng-Orn Evans; Carlos S Moreno; Xianquan Zhan; Michael T McCabe; Paula M Vertino; Dominic M Desiderio; Nelson M Oyesiku
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

6.  Novel Designed Proteolytically Resistant VEGF-B186R127S Promotes Angiogenesis in Mouse Heart by Recruiting Endothelial Progenitor Cells.

Authors:  Rahul Mallick; Erika Gurzeler; Pyry I Toivanen; Tiina Nieminen; Seppo Ylä-Herttuala
Journal:  Front Bioeng Biotechnol       Date:  2022-08-04

Review 7.  Angiogenesis in cancer: molecular mechanisms, clinical impact.

Authors:  M E Eichhorn; A Kleespies; M K Angele; K-W Jauch; C J Bruns
Journal:  Langenbecks Arch Surg       Date:  2007-02-16       Impact factor: 2.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.